Related Experiment Video
Updated: Sep 18, 2025

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
A Case of Rectal Malakoplakia Associated With Crohn's Disease: An Incidental Finding
Jean C Lafontaine Álvarez1, Gabriela Portilla Skerret2, María J Marcos Martínez1
1Pathology and Laboratory Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, PRI.
Abstract:
Malakoplakia is a rare granulomatous disorder characterized by defective phagolysosomal activity in macrophages and the presence of Michaelis-Gutmann (MG) bodies, often affecting immunosuppressed individuals. Although it most frequently involves the genitourinary tract, gastrointestinal involvement - particularly in the rectum and sigmoid colon - has been documented. We report a rare case of rectal malakoplakia in a 28-year-old female with penetrating ileocolonic Crohn's disease (CD) on infliximab. During surveillance colonoscopy, distal rectal mucosal nodularity, erythema, and friability were noted. Histopathology showed foamy histiocytes containing periodic acid Schiff-positive, diastase-resistant MG bodies, and CD68 confirmed histiocytic origin. A diagnosis of rectal malakoplakia was rendered, and the patient was managed with ciprofloxacin while continuing immunosuppressive therapy and a scheduled follow-up colonoscopy. Malakoplakia may mimic malignancy or inflammatory bowel disease clinically and endoscopically, making histologic evaluation essential for accurate diagnosis. Escherichia coli is the most commonly implicated organism, and fluoroquinolones are typically effective treatments. Surgical intervention is generally reserved for refractory cases. This case highlights the need to consider malakoplakia in the differential diagnosis of atypical rectal lesions in immunosuppressed patients, including those with CD, to ensure timely and appropriate management.
Insights
Malakoplakia, a rare disorder of defective macrophage function, can affect the rectum, especially in immunosuppressed patients with Crohn's disease. Early diagnosis through histology is crucial for appropriate management with antibiotics.
Area of Science:
- Gastroenterology
- Pathology
- Immunology
Background:
- Malakoplakia is a rare granulomatous condition characterized by defective phagolysosomal activity and Michaelis-Gutmann (MG) bodies.
- While typically affecting the genitourinary tract, gastrointestinal involvement, particularly rectal, is documented.
Observation:
- A case of rectal malakoplakia in a 28-year-old female with Crohn's disease on infliximab is presented.
- Colonoscopy revealed rectal mucosal nodularity, erythema, and friability.
- Histopathology confirmed foamy histiocytes with MG bodies, indicating malakoplakia.
Findings:
- The patient was diagnosed with rectal malakoplakia and treated with ciprofloxacin.
- Escherichia coli is the most common causative organism, and fluoroquinolones are effective treatments.
- Surgical intervention is reserved for refractory cases.
Implications:
- Rectal malakoplakia can mimic malignancy or inflammatory bowel disease, necessitating histological evaluation.
- This case underscores the importance of considering malakoplakia in immunosuppressed patients with atypical rectal lesions.
- Timely diagnosis and management are essential for patients with Crohn's disease and co-occurring malakoplakia.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

